Diabetes mellitus is a worldwide prevalent chronic disease with a significant disease burden. The associated dyslipidemia adds to the lethality of type 2 diabetes mellitus and requires newer and better treatment strategies. Peroxisome proliferator activated receptor (PPAR) α and γ agonists are approved hypolipidemic and anti-diabetic agents respectively and combining them together provides a dual benefit in type 2 diabetes mellitus associated with dyslipidemia. This novel class of dual PPAR agonists are termed as "Glitazars" and in 2013, Saroglitazar, a member of this class of drugs; was approved by the Indian regulatory authority Drug Controller General of India (DCGI) for the treatment of diabetic dyslipidemia. It is the first glitazar to gain regulatory approval anywhere in the world and is also the first New Chemical Entity (NCE) to be discovered in India. This review provides an overview of this novel drug including its mechanism of action and prospective uses.

BACKGROUND: Surgery of inferior turbinates is a divisive subject. Surgical management includes functional and invasive procedures. Radiofrequency ablation-A Minimally invasive welldesigned daycare nasal surgery which also preserves mucosal function of the inferior turbinate. OBJECTIVE: To appraise the efficacy of radiofrequency in the management of inferior turbinate hypertrophy. MATERIALS AND METHODS: current study is a prospective cram conducted in the Department of ENT from August 2013 to August 2014 with 100 patients who had nasal obstruction due to Inferior turbinate hypertrophy and obstinate to medical therapy. Patients were excluded if they had history or physical examination that indicate other causes of nasal obstruction like nasal polyp, nasal tumors, previous nasal surgeries, diabetes mellitus, severe nasal deformities, coagulopathy disorders, severe systemic diseases, radiotherapy to nose. The study was based on history of diagnosis, clinical examination, diagnostic nasal endoscopy and imaging. We used radio frequency generator BM-780II unit with power of 70watt radio wave emission in bipolar mode for 5-9seconds, stopped the emission once visual blanching of mucous membrane occurred. Postoperative follow up scheduled as follows: 1 st month, 3 rd month, 6 th month, 12 th month. RESULTS: Among 100 patients 92 patients completely relieved of symptoms, 8 patients showed no improvement based on both subjective and objective parameters. CONCLUSIONS: Simple, harmless, minimally invasive, daycare procedure advantages made the Radiofrequency tissue ablation procedure as one amongst the best apt surgical option for management of inferior turbinate hypertrophy and the current study added credit to its efficiency once again.

No abstract